Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells

Immunity. 1995 Oct;3(4):475-84. doi: 10.1016/1074-7613(95)90176-0.

Abstract

Type 1 interferons alpha and beta are found to be potent inhibitors of IL-7-induced growth of early B lineage cells, while having no effect on cell growth induced by IL-2, IL-3, IL-4, or autogenous factors. The combination of IL-7 and interferons alpha/beta induces bcl-2 down-regulation and cell death by apoptosis. These conclusions were derived initially from experiments employing exogenous cytokines, but functional type 1 interferons are also shown to be produced by resident bone marrow macrophages. As physiological modulators of IL-7-driven proliferation and cell survival, interferons alpha/beta may cooperate with other homeostatic factors to maintain the balanced production of normal B lineage cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • B-Lymphocytes / immunology*
  • Base Sequence
  • Bone Marrow / immunology
  • Bone Marrow Cells
  • Cell Differentiation / drug effects
  • Cell Division / drug effects
  • Cell Line
  • Cell Survival / drug effects
  • Drug Antagonism
  • Immunophenotyping
  • Interferon Type I / immunology
  • Interferon Type I / pharmacology*
  • Interleukin-7 / pharmacology*
  • Macrophages / immunology*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Transgenic
  • Molecular Sequence Data

Substances

  • Interferon Type I
  • Interleukin-7